Literature DB >> 15824744

Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies.

M R Munafò1, L Bowes, T G Clark, J Flint.   

Abstract

There is strong evidence for a genetic contribution to schizophrenia, but the contribution of individual candidate genes remains uncertain. We attempted to replicate a recent meta-analysis that reported an association of the catechol O-methyltransferase (COMT) Val allele with schizophrenia, and suggested that this effect may be moderated by ancestry. We included reports published subsequent to the original meta-analysis, and included a formal test of the moderating effect of ancestry in order to test whether the association operates differently in populations of European ancestry compared to populations of Asian ancestry. A corrected P-value for the 5% significance threshold was employed where appropriate, using Bonferroni's method, and studies that demonstrated departure from Hardy-Weinberg equilibrium among controls were excluded. When all studies were included in a meta-regression, there was evidence for a significant association of COMT Val allele frequency with schizophrenia case status and a significant main effect of ancestry. The interaction of COMT Val allele frequency and ancestry was also significant. However, when only studies that reported allele frequencies that did not depart significantly from Hardy-Weinberg equilibrium among controls were included, these effects were no longer significant. The results of our meta-analysis do not support an association between the COMT Val allele and schizophrenia case status, and do not support recent claims that this association may be moderated by ancestry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824744     DOI: 10.1038/sj.mp.4001664

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  76 in total

1.  COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.

Authors:  Dina Collip; Ruud van Winkel; Odette Peerbooms; Tineke Lataster; Viviane Thewissen; Marielle Lardinois; Marjan Drukker; Bart P F Rutten; Jim Van Os; Inez Myin-Germeys
Journal:  CNS Neurosci Ther       Date:  2010-11-14       Impact factor: 5.243

Review 2.  Genetics of developmental psychiatric disorders: pathways to discovery.

Authors:  Ridha Joober; Sarojini Sengupta; Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2005-09       Impact factor: 6.186

3.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-Hung Cheng; Stephen V Faraone; Marsha Wilcox; Stephen J Glatt; Fangming Gao; Cassandra L Smith; Rahim Shafa; Batol Aeali; Julie Carnevale; Hongjie Pan; Panagiotis Papageorgis; Jose F Ponte; Vadivelu Sivaraman; Ming T Tsuang; Sam Thiagalingam
Journal:  Hum Mol Genet       Date:  2006-09-19       Impact factor: 6.150

Review 4.  [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].

Authors:  P Falkai; W Maier
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

5.  The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.

Authors:  Zhao Zhang; Klaus Lindpaintner; Ronglin Che; Zangdong He; Peng Wang; Ping Yang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

Review 6.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Impact of interacting functional variants in COMT on regional gray matter volume in human brain.

Authors:  Robyn Honea; Beth A Verchinski; Lukas Pezawas; Bhaskar S Kolachana; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Neuroimage       Date:  2008-11-21       Impact factor: 6.556

8.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

9.  Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.

Authors:  Amy L Silberschmidt; Scott R Sponheim
Journal:  Schizophr Res       Date:  2008-01-16       Impact factor: 4.939

10.  MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met.

Authors:  Joshua L Roffman; Randy L Gollub; Vince D Calhoun; Thomas H Wassink; Anthony P Weiss; Beng C Ho; Tonya White; Vincent P Clark; Jill Fries; Nancy C Andreasen; Donald C Goff; Dara S Manoach
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.